On Thursday, in a major step forward in pain management, the U.S. Food and Drug Administration has approved a new nonopioid ...
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...
In a compelling validation of InvestingPro's Fair Value analysis, Pacira BioSciences (NASDAQ:PCRX) has delivered an impressive 61.78% return since being identified as significantly undervalued in ...
49mon MSN
The U.S. Food and Drug Administration said it approved Boston-based Vertex Pharmaceuticals' Journavx for short-term pain that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback